The survival impact of stromal tumor-infiltrating lymphocytes for patients with metastatic urothelial carcinoma treated with cisplatin-based chemotherapy

被引:0
|
作者
Hsieh, M-C. [1 ]
Huang, H-S. [1 ]
Su, Y-L. [1 ]
Chiang, P-H. [1 ]
Huang, C-H. [1 ]
机构
[1] Chang Gung Mem Hosp Kaohsiung, Hematol & Oncol, Kaohsiung, Taiwan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
276P
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Tailored Selection of First-Line Cisplatin-Based Chemotherapy in Patients with Metastatic Urothelial Carcinoma of Bladder
    Hsieh, Meng-Che
    Huang, Cheng-Hua
    Chiang, Po-Hui
    Chen, Yen-Yang
    Tang, Yeh
    Su, Yu-Li
    JOURNAL OF CANCER, 2016, 7 (10): : 1347 - 1352
  • [22] Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder
    Dash, Atreya
    Galsky, Matthew D.
    Vickers, Andrew J.
    Serio, Angel M.
    Koppie, Theresa M.
    Dalbagni, Guido
    Bochner, Bernard H.
    CANCER, 2006, 107 (03) : 506 - 513
  • [23] Cisplatin-based combination chemotherapy in septuagenarians with metastatic urothelial cancer
    Galsky, Matthew D.
    Krege, Susan
    Lin, Chia-Chi
    Hahn, Noah
    Ecke, Thorsten H.
    Moshier, Erin
    Sonpavde, Guru
    Godbold, James
    Oh, William K.
    Bamias, Aristotle
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 30.e15 - 30.e21
  • [24] Tumor-Infiltrating Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Patients with Breast Carcinoma
    Hornychova, Helena
    Melichar, Bohuslav
    Tomsova, Marketa
    Mergancova, Jindiska
    Urminska, Hana
    Ryska, Ales
    CANCER INVESTIGATION, 2008, 26 (10) : 1024 - 1031
  • [25] Prognostic significance of the tumor budding and tumor-infiltrating lymphocytes in survival of hepatocellular carcinoma patients
    Shafiq, Ahmed Mahran
    Taha, Noura Ali
    Zaky, Amen Hamdy
    Mohammed, Abdallah Hedia
    Omran, Ola M.
    Abozaid, Lobaina
    Ahmed, Hagir H. T.
    Ameen, Mahmoud Gamal
    INTERNATIONAL JOURNAL OF HEALTH SCIENCES-IJHS, 2024, 18 (06): : 10 - 19
  • [26] Tumor-Infiltrating Lymphocyte Volume Is a Better Predictor of Disease-Free Survival Than Stromal Tumor-Infiltrating Lymphocytes in Invasive Breast Carcinoma
    Fard, Elmira Vaziri
    Ali, Yasir
    Wang, Xiaohong, I
    Saluja, Karan
    Covinsky, Michael H.
    Wang, Lei
    Zhang, Songlin
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2019, 152 (05) : 656 - 665
  • [27] Predictive value of stromal tumor-infiltrating lymphocytes in patients with breast cancer treated with neoadjuvant chemotherapy: A meta-analysis
    Xia, Guangfa
    Zhang, Ziran
    Jiang, Qin
    Wang, Huan
    Wang, Jie
    MEDICINE, 2024, 103 (06) : E36810
  • [28] Tumor infiltrating lymphocytes (TIL) assessment in muscle invasive bladder cancer (MIBC) patients treated with cisplatin-based neoadjuvant chemotherapy (NAC) and surgery
    Chanza, Nieves Martinez
    Hamid, Anis
    Salgado, Roberto
    Gevaert, Thomas
    Maetens, Marion
    Rorive, Sandrine
    Aftimos, Philippe Georges
    Sideris, Spyridon
    Gil, Thierry
    Awada, Ahmad
    Roumeguere, Thierry Andre
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [29] CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma
    Sharma, Padmanee
    Shen, Yu
    Wen, Sijin
    Yamada, Sachiko
    Jungbluth, Achim A.
    Gnjatic, Sacha
    Bajorin, Dean F.
    Reuter, Victor E.
    Herr, Harry
    Old, Lloyd J.
    Sato, Eiichi
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (10) : 3967 - 3972
  • [30] Administration of Cisplatin-Based Chemotherapy for Advanced Urothelial Carcinoma in the Community
    Sonpavde, Guru
    Watson, Deidre
    Tourtellott, Marcia
    Cowey, C. Lance
    Hellerstedt, Beth
    Hutson, Thomas E.
    Zhan, Feng
    Vogelzang, Nicholas J.
    CLINICAL GENITOURINARY CANCER, 2012, 10 (01) : 1 - 5